Bond. Enzyme Bond. CurieCo's Erika Milczek on Replacing Chemicals with Biotech
Karl and Erum sit down with Erika Milczek, CEO and founder of Curie Co, to explore how synthetic biology is rewriting the rules of modern chemistry. Erika, a former Merck chemist, shares her journey from Big Pharma to launching a biotech startup that engineers enzymes to replace legacy chemicals in personal care and consumer goods. With insights grounded in regulatory shifts, manufacturing scalability, and the power of directed evolution, Erika discusses how her team is building a “biotech alternative to petroleum-based chemistry.” Whether you're curious about enzyme engineering, bioindustrial startups, or how synthetic biology can drive sustainability in everyday products, this episode delivers a high-energy, deeply technical, and inspiring dive into the future of materials innovation.
Chapters:
00:00:00 - Welcome to the Future: Setting the Stage
00:00:22 - Juggling Labs, Life, and Launchpads
00:01:27 - Terraforming Mars? Let’s Dream Big
00:04:58 - Joe Rogan, Speciation, and Sci-Fi Tangents
00:10:08 - Biotech Beauty Week: Innovation on Display
00:14:13 - Meet Erika Milczek: Enzymes Over Everything
00:33:03 - Feeding the Bug: The Spark Behind Discovery
00:35:15 - Scaling Science: What Makes Commercialization Hard
00:35:51 - Why Partnerships Make or Break Biotech
00:38:02 - Following the Rules: Regulatory Shifts & Product Strategy
00:42:48 - From the Lab to RTP: Building in Biotech's Backyard
00:45:37 - Ecosystem First: How to Build Bio Economies
00:50:01 - Fundraising Real Talk: Investors, Guts & Growth
00:53:50 - Biomanufacturing Is Just Getting Started
00:56:29 - Let’s Talk Packaging: Biotech’s Next Frontier
00:59:52 - Wrapping Up: Lessons, Hope, and What’s Next
